ID
13704
Beschrijving
A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00620321
Link
https://clinicaltrials.gov/show/NCT00620321
Trefwoorden
Versies (1)
- 29-02-16 29-02-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
29 februari 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Myeloid Leukemia NCT00620321
Eligibility Acute Myeloid Leukemia NCT00620321
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication within 14 or 21 days of the initial dose of study drug for a non-myelosuppressive or myelosuppressive agent, respectively.
Datatype
boolean
Alias
- UMLS CUI [1]
- C1514463
Beschrijving
patients with acute promyelocytic leukemia (apml).
Datatype
boolean
Alias
- UMLS CUI [1]
- C0023487
Beschrijving
major surgery within 4 weeks of study enrollment.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0679637
Beschrijving
patients with serious pre-existing medical conditions (at the discretion of the investigator). because of the known cardiac toxicity of anthra- cyclines, patients with pre-existing ejection fraction (ef) less than or equal to 45% should not participate in this study. no patient should exceed the maximum exposure of anthracycline doses (for example, idarubicin greater than 120mg/m2).
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009488
- UMLS CUI [2]
- C0232174
- UMLS CUI [3]
- C0282564
Beschrijving
patients with a second malignancy that could affect the interpretation of the results.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0006826
Beschrijving
patients with leukemic involvement of the cns by spinal fluid cytology or imaging.
Datatype
boolean
Alias
- UMLS CUI [1]
- C1332884
Beschrijving
patients with known coagulopathy or bleeding disorder, other than leukemia related thrombocytopenia. patients with severe of life threatening bleeding refractory to platelet transfusions are also excluded.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0005779
Beschrijving
concomitant anticoagulant therapy (with the exception of heparinized saline to maintain the patency of central venous catheters).
Datatype
boolean
Alias
- UMLS CUI [1]
- C0150457
Beschrijving
women who are pregnant or breast feeding.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Beschrijving
patients with a known hypersensitivity to oligonucleotides, idarubicin, and/or cytarabine.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0028953
- UMLS CUI [1,2]
- C0020517
- UMLS CUI [2,1]
- C0020789
- UMLS CUI [2,2]
- C0020517
- UMLS CUI [3,1]
- C0010711
- UMLS CUI [3,2]
- C0020517
Similar models
Eligibility Acute Myeloid Leukemia NCT00620321
- StudyEvent: Eligibility
C0205269 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,3])
C1531552 (UMLS CUI [2])
C1444662 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C0279025 (UMLS CUI [4,1])
C1444662 (UMLS CUI [4,2])
C0949266 (UMLS CUI [5,1])
C1444662 (UMLS CUI [5,2])
C2004454 (UMLS CUI [6])
C0020402 (UMLS CUI [7])
C0700589 (UMLS CUI [2])
C0232174 (UMLS CUI [2])
C0282564 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
C0020517 (UMLS CUI [1,2])
C0020789 (UMLS CUI [2,1])
C0020517 (UMLS CUI [2,2])
C0010711 (UMLS CUI [3,1])
C0020517 (UMLS CUI [3,2])